Trial Profile
A safety and tolerability trial of repeated doses of tirasemtiv in patient with amyotrophic lateral sclerosis.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Tirasemtiv (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- 03 Dec 2015 New trial record